-
PHOLORLA 25 Drug name: PHOLORLA 25 Generic name: Lorlatinib tablets/Lorlatinib
Regular price ¥1,500.00 CNYRegular priceUnit price per -
Brigatinib 90mg Brigatinib is a kinase inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib.
Regular price ¥500.00 CNYRegular priceUnit price per¥1,000.00 CNYSale price ¥500.00 CNYSale -
Brigatinib INN equivalent to Brigatinib......... 90mg
Regular price ¥550.00 CNYRegular priceUnit price per -
Beigani brigatinib 90mg 21TABLES Approval No. 08 L 0809/19 Expiration Date 06-9-2025
Regular price ¥750.00 CNYRegular priceUnit price per¥1,500.00 CNYSale price ¥750.00 CNYSale -
Brigatinib 180mg Brigatinib is a kinase inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib.
Regular price ¥750.00 CNYRegular priceUnit price per¥1,800.00 CNYSale price ¥750.00 CNYSale -
BRIGAMAKS Drug name: BRIGAMAKS Generic name: Brigatinib tablets/Brigatinib
Regular price ¥650.00 CNYRegular priceUnit price per¥1,000.00 CNYSale price ¥650.00 CNYSale -
Ceritinib is indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) that is positive for anaplastic lymphoma kinase (ALK) as detected by an FDA-approved test.
Regular price ¥1,170.00 CNYRegular priceUnit price per¥1,600.00 CNYSale price ¥1,170.00 CNYSale -
色瑞替尼 Cerini （Ceritinib） Cerini，品名：色瑞替尼，通用名：Ceritinib，适用为有间变性淋巴瘤激酶（ALK）-阳性转移，对克唑替尼治疗出现疾病进展或不能耐受的非小细胞肺癌（NSCLC）患者的治疗。
Regular price ¥1,725.00 CNYRegular priceUnit price per -
Alectinib is indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test.
Regular price ¥1,275.00 CNYRegular priceUnit price per¥1,800.00 CNYSale price ¥1,275.00 CNYSale -
Alectinib 150mg 56TABLES Approval No. 08 L 0811/19 Expiration Date 06-9-2025
Regular price ¥1,800.00 CNYRegular priceUnit price per¥3,000.00 CNYSale price ¥1,800.00 CNYSale -
Crizotinib 250MG 60'S Approval No. 03 L 0847/21 Validity Date 06-8-2027
Regular price ¥1,200.00 CNYRegular priceUnit price per¥2,000.00 CNYSale price ¥1,200.00 CNYSale -
Kayzoni CRIZOTINIB 250MG, 60 CAPS Approval No. 12 L 0751/17 Expiration Date 20-8-2027
Regular price ¥1,750.00 CNYRegular priceUnit price per¥3,500.00 CNYSale price ¥1,750.00 CNYSale -
Crizotinib is a first-generation targeted drug for non-small cell lung cancer with ALK mutation
Regular price ¥1,200.00 CNYRegular priceUnit price per¥2,500.00 CNYSale price ¥1,200.00 CNYSale -
CRIZOMAKS 250 rizotinib250mg 60 tablets
Regular price ¥1,200.00 CNYRegular priceUnit price per -
Crizotinib, KESODX, Crizotinib
Regular price ¥1,350.00 CNYRegular priceUnit price per¥2,000.00 CNYSale price ¥1,350.00 CNYSale
